These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 23273345)
21. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230 [TBL] [Abstract][Full Text] [Related]
22. Free flap reconstruction after surgical release of oral submucous fibrosis: long-term maintenance and its clinical implications. Chan RC; Wei FC; Tsao CK; Kao HK; Chang YM; Tsai CY; Chen WH J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):344-9. PubMed ID: 24530059 [TBL] [Abstract][Full Text] [Related]
23. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Lee CH; Ko YC; Huang HL; Chao YY; Tsai CC; Shieh TY; Lin LM Br J Cancer; 2003 Feb; 88(3):366-72. PubMed ID: 12569378 [TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population. Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542 [TBL] [Abstract][Full Text] [Related]
25. Oral potentially malignant disorders: risk of progression to malignancy. Speight PM; Khurram SA; Kujan O Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):612-627. PubMed ID: 29396319 [TBL] [Abstract][Full Text] [Related]
26. [Cell morphometric analysis in oral submucous fibrosis, leukoplakia and squamous cell carcinoma]. Gao S Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 May; 27(3):145-7, 189. PubMed ID: 1292898 [TBL] [Abstract][Full Text] [Related]
27. DNA content abnormality in oral submucous fibrosis concomitant leukoplakia: A preliminary evaluation of the diagnostic and clinical implications. Xiao X; Hu Y; Li C; Shi L; Liu W Diagn Cytopathol; 2020 Nov; 48(11):1111-1114. PubMed ID: 32433822 [TBL] [Abstract][Full Text] [Related]
28. [Precancerous lesions of the buccal mucosa]. Ben Slama L Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145 [TBL] [Abstract][Full Text] [Related]
29. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors. Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712 [TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population. Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312 [TBL] [Abstract][Full Text] [Related]
31. Incidence rates of oral cancer and oral pre-cancerous lesions in a 6-year follow-up study of a Taiwanese aboriginal community. Yang YH; Chen CH; Chang JS; Lin CC; Cheng TC; Shieh TY J Oral Pathol Med; 2005 Nov; 34(10):596-601. PubMed ID: 16202079 [TBL] [Abstract][Full Text] [Related]
32. Growth-regulated oncogene-α from oral submucous fibrosis fibroblasts promotes malignant transformation of oral precancerous cells. Ye MY; Chen MY; Chang YH; Huang JS; Huang TT; Wong TY; Hong TM; Chen YL J Oral Pathol Med; 2018 Oct; 47(9):880-886. PubMed ID: 30035347 [TBL] [Abstract][Full Text] [Related]
33. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature. Auluck A; Rosin MP; Zhang L; Sumanth KN J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065 [TBL] [Abstract][Full Text] [Related]
34. The frequency and malignant transformation rate of oral lichen planus and leukoplakia--a retrospective study. Brzak BL; Mravak-Stipetić M; Canjuga I; Baricević M; Balicević D; Sikora M; Filipović-Zore I Coll Antropol; 2012 Sep; 36(3):773-7. PubMed ID: 23213931 [TBL] [Abstract][Full Text] [Related]
35. Clinical features and presentation of oral potentially malignant disorders. Warnakulasuriya S Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):582-590. PubMed ID: 29673799 [TBL] [Abstract][Full Text] [Related]
36. In vivo autofluorescence spectroscopy of oral premalignant and malignant lesions: distortion of fluorescence intensity by submucous fibrosis. Tsai T; Chen HM; Wang CY; Tsai JC; Chen CT; Chiang CP Lasers Surg Med; 2003; 33(1):40-7. PubMed ID: 12866120 [TBL] [Abstract][Full Text] [Related]
37. Comparing dose-response measurements of oral habits on oral leukoplakia and oral submucous fibrosis from a community screening program. Yang YH; Ho PS; Lu HM; Huang IY; Chen CH J Oral Pathol Med; 2010 Apr; 39(4):306-12. PubMed ID: 20149061 [TBL] [Abstract][Full Text] [Related]
38. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications. Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267 [TBL] [Abstract][Full Text] [Related]